Dr. Joseph Chang Launches Update to Bestselling Book "The Aging Myth" With 15 More Years of Breakthrough Research on Cellular Wellness
Nu Skin Enterprises (NYSE:NUS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Stonegate Attends ICR 2026, Highlighted by Fireside Chat with Nu Skin (NUS) [Yahoo! Finance]
Nu Skin Enterprises to Announce Fourth Quarter and Full Year 2025 Financial Results
Nu Skin Enterprises to Discuss Company Strategy and Opportunities at ICR Conference